Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 2.69 CAD Market Closed
Market Cap: 86.8m CAD

Wall Street
Price Targets

MDP Price Targets Summary
Medexus Pharmaceuticals Inc

Wall Street analysts forecast MDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDP is 6.24 CAD with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.

Lowest
Price Target
3.48 CAD
30% Upside
Average
Price Target
6.24 CAD
132% Upside
Highest
Price Target
10.5 CAD
290% Upside
Medexus Pharmaceuticals Inc Competitors:
Price Targets
ALM
Almirall SA
25% Upside
JNJ
Johnson & Johnson
15% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
20% Upside
OGI
OrganiGram Holdings Inc
54% Upside
4536
Santen Pharmaceutical Co Ltd
31% Upside
COPN
Cosmo Pharmaceuticals NV
89% Upside
CLN
Celon Pharma SA
15% Upside

Revenue
Forecast

Revenue Estimate
Medexus Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 53%. The projected CAGR for the next 4 years is 6%.

53%
Past Growth
6%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 4 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Medexus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDP's stock price target?
Price Target
6.24 CAD

According to Wall Street analysts, the average 1-year price target for MDP is 6.24 CAD with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.

What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 53%. The projected CAGR for the next 4 years is 6%.

What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
28%

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 4 years is 28%.

Back to Top